Human lymphoid cell lines: Models for immunological analysis

Summary Investigations with human long term lymphoid cell lines have amply demonstrated the versatility of these tissue culture systems for the detection, definition, and solution of current problems in cell biology, biochemistry, genetics, and immunology. These systems are contributing much to our understanding of the multiple functions of lymphoid cells in the immune response. Human lymphoid cell lines produce, in large quantities, the putative extracellular mediators of cell-mediated immunity, including migration inhibitory factor (MIF), lymphotoxin, interferon, and a specific, reversible inhibitor of lymphocyte biosynthetic activity. The MIF released by human lymphoid cell lines is similar to that produced by phytomitogen- or antigen-stimulated human peripheral lymphocytes. Human lymphoid cells from lines producing MIF mimic the capillary migration patterns of guinea pig peritoneal macrophages, and are more sensitive than the guinea pig cells to human MIFs. Studies with these migrating cells indicate that MIF is not solely a lymphoid cell product, but is synthesized by a wide variety of activated cell types. Extracts of cultured human lymphoid cells inhibit the synthesis of RNA, protein, and DNA by established lymphoid cell lines and by phytomitogen-stimulated human peripheral lymphocytes, but have no inhibitory effects on human nonlymphoid cells. The reversible inhibition is produced with physiological quantities of extract, suggesting a functional immunoregulatory activity for this material in lymphocyte-mediated immunological reactions. Initial findings indicate that these mediators are multiple and distinct molecular species. The remarkable proliferative and synthetic potential of human lymphoid cell systems provides a most useful resource for the purification and characterization of these immunological substances. This invited paper was presented at the Hematopoietic Systems Sessions in Depth section of the 24th Annual Meeting of the Tissue Culture Association, Inc., Boston, June 4, 1973. The work was supported by Grants RO1-AI10422 and TO1-AI00445 from the National Institute of Allergy and Infectious Diseases and PO1-GM19443 from the National Institute of General Medical Sciences of the National Institute of Health, United States Public Health Service. Recipient of Research Career Development Award AI46371 from the National Institutes of Allergy and Infectious Diseases, National Institutes of Health.